Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat
Conditions
Interventions
- DRUG: Nirogacestat
- DRUG: Nirogacestat and Famotidine
- DRUG: Nirogacestat and Rabeprazole
Sponsor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany